Twice-yearly depemokimab maintains clinically meaningful response over 2 years in patients with uncontrolled asthma symptoms at baseline: Responder analysis of the integrated SWIFT/AGILE studies
作者
Ian Douglas Pavord,Geoffrey Lowell Chupp,David J Jackson,Claire E. Tacon,Diana Jarreta,Richard Forth,Daniel J Jackson
出处
期刊:The European respiratory journal [European Respiratory Society] 日期:2026-09-05卷期号:: OA1286-OA1286